Spectrum Pharmaceuticals, Inc. 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-30 4:11 pm Sale |
2021-04-26 | 13D | CASI Pharmaceuticals, Inc. CASI |
SPECTRUM PHARMACEUTICALS INC SPPI |
688,696 4.900% |
-234,736 (-25.42%) |
Filing |
| 2020-08-18 4:04 pm Purchase |
2020-08-18 | 13D | CASI Pharmaceuticals, Inc. CASI |
SPECTRUM PHARMACEUTICALS INC SPPI |
923,432 7.500% |
923,432 (New Position) |
Filing |